Wednesday, 2 July 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 02 July 2025
News

Lilly pulls presentation for top drug

Posted 30 June 2025 PM

All strengths of Mounjaro vials have officially been exhausted after Eli Lilly decided to discontinue the presentation in 2024 and swap to the KwikPen, a multidose delivery option of the pegged blockbuster.

Mounjaro KwikPen is available on private script for the treatment of adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise as monotherapy when metformin is not tolerated, or contradicted, or in addition to other glycaemic control medications.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (10)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (1)

Devices (1)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.